蒋收获, 谢洪彬, 贝文, 徐一鸣, 孙心怡, 谢作帆, 卢伟. 互联网医疗规制风险分析[J]. 上海预防医学, 2021, 33(8): 672-677. DOI: 10.19428/j.cnki.sjpm.2021.20930
引用本文: 蒋收获, 谢洪彬, 贝文, 徐一鸣, 孙心怡, 谢作帆, 卢伟. 互联网医疗规制风险分析[J]. 上海预防医学, 2021, 33(8): 672-677. DOI: 10.19428/j.cnki.sjpm.2021.20930
JIANG Shou-huo, XIE Hong-bin, BEI Wen, XU Yi-ming, SUN Xin-yi, XIE Zuo-fan, LU Wei. Risk analysis of internet medicine regulation[J]. Shanghai Journal of Preventive Medicine, 2021, 33(8): 672-677. DOI: 10.19428/j.cnki.sjpm.2021.20930
Citation: JIANG Shou-huo, XIE Hong-bin, BEI Wen, XU Yi-ming, SUN Xin-yi, XIE Zuo-fan, LU Wei. Risk analysis of internet medicine regulation[J]. Shanghai Journal of Preventive Medicine, 2021, 33(8): 672-677. DOI: 10.19428/j.cnki.sjpm.2021.20930

互联网医疗规制风险分析

Risk analysis of internet medicine regulation

  • 摘要: 互联网与医疗行业融合,无论是速度还是规模与其他行业相比都显得明显落后,究其原因,与互联网医疗的高风险、难监管密不可分。本文基于规制语境,分析互联网医疗的内生风险与外生风险。互联网的内在特性,如开放性、差异性、多主体性、虚拟性、透明性、高度聚集性等可导致管辖争议、权利义务责任主体难以确定性、个人信息及医疗信息安全性、垄断性等内生风险。互联网医疗专项法律跟进滞后、传统科层制监管体系缺乏延展性和协同性、互联网医院监管政策细节未定、互联网诊疗技术规范操作规程缺乏等外在制度覆盖滞后又产生规制盲区,引发外生风险。需要在风险分析的基础上探讨进一步构建风险评估机制和监管机制。

     

    Abstract: The penetration and integration of internet with medical industry is apparently falling behind its interaction with other industries in terms of speed and scale. The main reason is due to the high risk and difficult supervision of internet medicine. Based on the regulatory context, this paper analyzes the endogenous and exogenous risk of internet medicine. The inherent characteristics of the internet (such as openness, diversity, multi subjectivity, virtuality, transparency, and high aggregation) lead to endogenous risks, including jurisdiction disputes, uncertainty of rights and obligations, security of personal information and medical information, monopoly. The lag of specific law in internet medicine, the lack of extensibility and synergy of traditional hierarchical regulatory system, the uncertainty of internet hospital regulatory policy details, the lack of technical specifications/operating procedures and other external system coverage in internet diagnosis and treatment lead to regulatory blind areas and exogenous risks. Based on the risk analysis, this paper discusses further construction of the mechanisms of risk assessment and regulation for internet medicine.

     

/

返回文章
返回